title: Olanzapine-induced elevation of plasma triglyceride levels.
authors.forename: B B
authors.initials: BB
authors.lastname: Sheitman
authors.forename: P M
authors.initials: PM
authors.lastname: Bird
authors.forename: W
authors.initials: W
authors.lastname: Binz
authors.forename: L
authors.initials: L
authors.lastname: Akinli
authors.forename: C
authors.initials: C
authors.lastname: Sanchez
mesh_terms: D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy; D014280:Triglycerides / Q000097:blood; D015430:Weight Gain
chemical_list: D014150:Antipsychotic Agents; D014280:Triglycerides; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine